Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

CD1-specific T cells in microbial immunity.

J E Gumperz1, M B Brenner

  • 1Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital and Harvard Medical School, Smith Building, Room 518, Boston, MA 02115, USA. jgumperz@rics.bwh.harvard.edu

Current Opinion in Immunology
|August 11, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

CD1a expression defines an interleukin-12 producing population of human dendritic cells.

Clinical and experimental immunology·2009
Same author

Reduced insulin secretion and content in VEGF-a deficient mouse pancreatic islets.

Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association·2008
Same author

Pathways of CD1 and lipid antigen delivery, trafficking, processing, loading, and presentation.

Current topics in microbiology and immunology·2007
Same author

Restoration of first-phase insulin secretion by the imidazoline compound LY374284 in pancreatic islets of diabetic db/db mice.

Annals of the New York Academy of Sciences·2004
Same author

Influence of Mycobacterium bovis bacillus Calmette Guérin on in vitro induction of CD1 molecules in human adherent mononuclear cells.

Infection and immunity·2001
Same author

Pathways for lipid antigen presentation by CD1 molecules: nowhere for intracellular pathogens to hide.

Traffic (Copenhagen, Denmark)·2001
Same journal

A blind spot of human T cell immunology: epitope specificity in secondary lymphoid organs.

Current opinion in immunology·2026
Same journal

Germinal center responses at barrier organ sites.

Current opinion in immunology·2026
Same journal

Ocular sarcoidosis: from clinical signs to targeted interventions.

Current opinion in immunology·2026
Same journal

On or within: spatial determinants of antigen handling in the nasal turbinates.

Current opinion in immunology·2026
Same journal

Decoding the complexity of intestinal immunity with spatial transcriptomics.

Current opinion in immunology·2026
Same journal

Reconsidering the immunological aspects of solid-phase assays for antiphospholipid antibodies detection.

Current opinion in immunology·2026
See all related articles

CD1-restricted T cells are crucial for fighting microbial infections. Studies show these cells respond strongly to Mycobacterium tuberculosis antigens and that activating related immune cells improves defense against pathogens.

Area of Science:

  • Immunology
  • Microbiology
  • Infectious Diseases

Background:

  • CD1-restricted T cells are increasingly recognized for their role in host defense against microbial infections.
  • Specific subsets, like CD1c-restricted T cells and CD1d-restricted NKT cells, are implicated in immune responses.

Purpose of the Study:

  • To investigate the role of CD1-restricted T cells in host defense against microbial pathogens.
  • To examine immune responses to microbial lipid antigens presented by CD1 molecules.

Main Methods:

  • Analysis of T cell responses in human subjects infected with Mycobacterium tuberculosis.
  • Assessment of CD1c-mediated presentation of microbial lipid antigens.
  • Evaluation of immune responses following activation of CD1d-restricted NKT cells with synthetic glycolipid antigens.

Related Experiment Videos

Main Results:

  • Elevated T cell responses to CD1c-presented Mycobacterium tuberculosis lipid antigens were observed in infected subjects compared to controls.
  • Activation of CD1d-restricted NKT cells using a synthetic glycolipid antigen enhanced immune responses against various infectious pathogens.

Conclusions:

  • These findings provide further evidence for the significant role of CD1-restricted T cells in combating microbial infections.
  • Targeting CD1-restricted T cell pathways, including NKT cell activation, represents a potential strategy for enhancing host defense against pathogens.